Wikidata

(Q34587751)

English

Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033.

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

title
Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033 (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18235122
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18235122%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 January 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q34587751&oldid=1979926970"